OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company headquartered in Miami, Florida, USA. It was founded in 2007 by Dr. Phillip Frost, a prominent entrepreneur and physician. OPKO Health is involved in the development and commercialization of pharmaceuticals and diagnostics, focusing on areas such as chronic kidney disease, infectious diseases, oncology, and more recently, COVID-19 testing and vaccines. The company operates through various subsidiaries and has a global presence in healthcare innovation and research.